Nrf2: a potential therapeutic target for diabetic neuropathy

Area of Science:

• Neuroscience
• Molecular Biology
• Endocrinology

Background:

• Diabetic neuropathy pathogenesis involves inflammatory and apoptotic pathways.
• Nuclear factor erythroid 2-related factor 2 (Nrf2) regulates antioxidant and detoxifying enzymes via the antioxidant response element (ARE).
• Nrf2 activity is modulated by hyperglycemia, a key factor in diabetic neuropathy.

Purpose of the Study:

• To summarize the evidence linking Nrf2 to the inflammatory and apoptotic pathways in diabetic neuropathy.
• To elucidate the role of Nrf2 in the progression of diabetic neuropathy.
• To explore the therapeutic potential of targeting Nrf2 activators for diabetic neuropathy treatment.

Main Methods:

• Review of existing literature on Nrf2, oxidative stress, inflammation, and diabetic neuropathy.
• Analysis of the regulatory mechanisms of Nrf2 under hyperglycemic conditions.
• Synthesis of data on the impact of Nrf2 downregulation on microvascular changes in diabetic neuropathy.

Main Results:

• Nrf2 acts as a crucial link between inflammatory and apoptotic pathways in diabetic neuropathy.
• Hyperglycemia, particularly persistent hyperglycemia, downregulates Nrf2 activity.
• Downregulation of Nrf2 leads to microvascular complications underlying diabetic neuropathy.

Conclusions:

• Nrf2 plays a significant role in the pathophysiology and progression of diabetic neuropathy.
• Targeting Nrf2 activators presents a promising therapeutic strategy for managing diabetic neuropathy.
• Further research into Nrf2 modulation could offer novel insights for diabetic neuropathy treatment.